Wave Life Sciences retains a Hold rating as WVE-007's Phase 1 data show target engagement and visceral fat reduction but minimal weight loss. WVE-007's efficacy in obesity remains unproven versus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results